Genmab | GEN - Credores Comerciais

Preço das Ações
1,639.00
Mudança Diária
-119.50 -6.80%
Mensal
-9.07%
Anual
24.26%
Q2 Previsão
1,613.20




Credores Comerciais Alterar Data
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Almirall EUR 258.05M 58.66M 2025-12
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
argenx SE USD 554.27M 297.94M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 7.08B 700M 2025-12
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Demant DKK 923M 41M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GN Store Nord DKK 1.01B 486M 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Insmed USD 73.38M 6.53M 2026-03
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Novartis USD 4.32B 134M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12